Digital intervention for treating depression and anxiety in teens
Digital Intervention for Depression and Anxiety in Adolescents
This study tests if a new digital program can help teenagers with depression and anxiety feel better compared to regular health education.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 10 Years to 18 Years |
| Sex | All |
| Sponsor | Adai Technology (Beijing) Co., Ltd. Academic / other |
| Locations | 1 site (Chengdu, Sichuang) |
| Trial ID | NCT06349993 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of digital interventions in alleviating symptoms of depression and anxiety among adolescents. Participants will engage with a digital platform for two months, and their outcomes will be compared to those receiving traditional health education methods. The study aims to determine whether the digital approach can provide significant improvements in mental health compared to conventional methods.
Who should consider this trial
Good fit: Ideal candidates are adolescents diagnosed with depression or anxiety who meet specific eligibility criteria.
Not a fit: Patients with severe psychiatric disorders, a history of substance dependence, or those at high risk of suicide may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could offer a novel and accessible treatment option for adolescents struggling with depression and anxiety.
How similar studies have performed: Other studies have shown promise in using digital interventions for mental health, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * The Mini International Neuropsychiatric Interview for Children and Adolescents (MINI-KID) will be used to assess participants' eligibility based on the diagnostic criteria for depression outlined in the DSM-5(the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition). * having a HAMD(Hamilton Depression scale) score upon enrollment * demonstrate normal cognitive function. * voluntarily agree to participate in the study, and both they and their legal guardians must provide informed consent. Exclusion Criteria: * with severe consciousness disorders and a history of psychiatric illness, traumatic brain injury, substance dependence, or acute poisoning * with concurrent psychiatric disorders (as determined by clinical assessment) * with concurrent psychiatric disorders (as determined by the assessing clinician) * at high risk of suicide
Where this trial is running
Chengdu, Sichuang
- West China Hospital — Chengdu, Sichuang, China (Recruiting)
Study contacts
- Study coordinator: Liqun Zhang
- Email: zhangliqun@adai-tech.com
- Phone: 010-85795371
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.